Compare KRYS & TFPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRYS | TFPM |
|---|---|---|
| Founded | 2015 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 6.8B |
| IPO Year | 2017 | 2022 |
| Metric | KRYS | TFPM |
|---|---|---|
| Price | $298.90 | $30.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 2 |
| Target Price | ★ $297.60 | $40.00 |
| AVG Volume (30 Days) | 273.5K | ★ 483.3K |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.72% |
| EPS Growth | ★ 128.00 | N/A |
| EPS | ★ 1.83 | N/A |
| Revenue | ★ $389,130,000.00 | N/A |
| Revenue This Year | $38.74 | $29.19 |
| Revenue Next Year | $32.53 | N/A |
| P/E Ratio | $166.58 | ★ $35.57 |
| Revenue Growth | ★ 33.94 | N/A |
| 52 Week Low | $123.03 | $21.45 |
| 52 Week High | $319.48 | $41.70 |
| Indicator | KRYS | TFPM |
|---|---|---|
| Relative Strength Index (RSI) | 55.98 | 38.94 |
| Support Level | $253.89 | $27.14 |
| Resistance Level | $319.48 | $36.05 |
| Average True Range (ATR) | 11.79 | 1.21 |
| MACD | -0.87 | -0.17 |
| Stochastic Oscillator | 46.86 | 3.28 |
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
Triple Flag Precious Metals Corp is a streaming and royalty company focused on precious metals. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Mexico, Mongolia, Peru, South Africa, and the United States. Its diversified portfolio of streams and royalties comprises long-life mining assets, including the Northparkes copper-gold mine in Australia, the Cerro Lindo polymetallic mine in Peru, the Fosterville gold mine in Australia, the Buritica gold mine in Colombia, and the Impala Bafokeng Operations in South Africa among others. A majority of its revenue is derived through its interests in various gold streams. Geographically, the company derives maximum revenue from Australia, followed by Peru and other regions.